Skip to main content

Together we are beating cancer

Donate now

Search Results: PARP inhibitors

Showing 12 out of 107 results

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments. Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

by Cancer Research UK | News | 5 September 2016

5 September 2016

  • Health & Medicine
  • Science & Technology

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments. Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

by British Journal of Cancer | News | 10 August 2016

10 August 2016

Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

by Cancer Research UK | Research Feature | 10 August 2016

10 August 2016

F1-Pitstop

We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge. We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge.

by Emma Smith | Analysis | 18 September 2015

18 September 2015

Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers

by Cancer Research UK | News | 16 July 2015

16 July 2015

Paper DNA

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes. A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

by Kat Arney | Analysis | 24 February 2015

24 February 2015

Professor Elaine Mardis at the NCRI

Here's our final round-up from the 2014 NCRI cancer conference in Liverpool Here's our final round-up from the 2014 NCRI cancer conference in Liverpool

by Henry Scowcroft | Analysis | 6 November 2014

6 November 2014

  • Science & Technology
  • Health & Medicine

NCRI 2014 conference summary - day 3

Here’s our round up from day three of the NCRI cancer conference in Liverpool. Here’s our round up from day three of the NCRI cancer conference in Liverpool.

by Nick Peel | Analysis | 5 November 2014

5 November 2014